In the last two years, Immunotech Biopharm Ltd's Price has grown from HK$0.00 to HK$0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach HK$0.00 – an increase of 100.00%. Over the next nine years, the forecast is for Fair Value to grow by 100.00%.

2022 Fair Value Forecast

HK$0.00

2023 Fair Value Forecast

HK$0.00

2024 Fair Value Forecast

HK$0.00

2025 Fair Value Forecast

HK$0.00

2026 Fair Value Forecast

HK$0.00

2027 Fair Value Forecast

HK$0.00

2028 Fair Value Forecast

HK$0.00

2029 Fair Value Forecast

HK$0.00

2030 Fair Value Forecast

HK$0.00

Immunotech Biopharm Ltd Revenue Forecast for 2023 - 2025 - 2030

Immunotech Biopharm Ltd Dividend per Share Forecast for 2023 - 2025 - 2030

Immunotech Biopharm Ltd Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last year, Immunotech Biopharm Ltd's Free Cash Flow has grown, rising from HK$-109.23M to HK$-288.71M – a growth of 164.31%. According to 0 prominent analysts, Immunotech Biopharm Ltd's Free Cash Flow will fall by 62.17% in the next year, reaching HK$-109.22M. By 2030, professionals believe that Immunotech Biopharm Ltd's Free Cash Flow will decrease by 13.41%, reaching HK$-250.00M – a concerning trend for the company.

2021 FCF Forecast

HK$-109218993.00

2022 FCF Forecast

HK$-206245505.75

2023 FCF Forecast

HK$-244146554.85

2024 FCF Forecast

HK$-326977342.70

2025 FCF Forecast

HK$-231183880.53

2026 FCF Forecast

HK$-231638542.16

2027 FCF Forecast

HK$-243923106.18

2028 FCF Forecast

HK$-273356494.33

2029 FCF Forecast

HK$-258768369.42

2030 FCF Forecast

HK$-249996121.69

Immunotech Biopharm Ltd Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Immunotech Biopharm Ltd's Net Income has grown by 225.57%, rising from HK$-108.80M to HK$-354.22M. For the next year, 0 analysts project Immunotech Biopharm Ltd's Net Income to drop by 9.11%, reaching HK$-321.96M. By 2030, professionals believe that Immunotech Biopharm Ltd's Net Income will decrease by 7.47%, reaching HK$-327.77M – a concerning trend for the company.

2022 NI Forecast

HK$-321962365.33

2023 NI Forecast

HK$-277692540.10

2024 NI Forecast

HK$-323891322.35

2025 NI Forecast

HK$-336523083.93

2026 NI Forecast

HK$-334201074.65

2027 NI Forecast

HK$-314906532.60

2028 NI Forecast

HK$-318129076.12

2029 NI Forecast

HK$-324290175.90

2030 NI Forecast

HK$-327770890.45

Immunotech Biopharm Ltd EBITDA Forecast for 2023 - 2025 - 2030

Immunotech Biopharm Ltd's EBITDA has grown In the last two years, rising from HK$-86.79M to HK$-331.41M – a growth of 281.85%. In the following year, 0 experts forecast Immunotech Biopharm Ltd's EBITDA will decrease by 24.15%, to HK$-251.37M. In 2030, professionals predict that Immunotech Biopharm Ltd's EBITDA will decrease by 19.75%, to HK$-265.96M.

2022 EBITDA Forecast

HK$-251374485.00

2023 EBITDA Forecast

HK$-216693185.22

2024 EBITDA Forecast

HK$-251811927.44

2025 EBITDA Forecast

HK$-280258281.51

2026 EBITDA Forecast

HK$-272691307.91

2027 EBITDA Forecast

HK$-253302955.91

2028 EBITDA Forecast

HK$-253530928.57

2029 EBITDA Forecast

HK$-262260843.55

2030 EBITDA Forecast

HK$-265958721.44

Immunotech Biopharm Ltd EBIT Forecast for 2023 - 2025 - 2030

Immunotech Biopharm Ltd's EBIT has seen impressive growth In the last two years, rising from HK$-97.73M to HK$-345.15M – a growth of 253.17%. According to 0 major analysts, Immunotech Biopharm Ltd's EBIT will fall by 23.47% in the next year, reaching HK$-264.14M. Professionals believe that By 2030, Immunotech Biopharm Ltd's EBIT will fall to HK$-278.67M– a 19.26% decrease from its current value.

2022 EBIT Forecast

HK$-264143295.00

2023 EBIT Forecast

HK$-228501559.73

2024 EBIT Forecast

HK$-264307754.14

2025 EBIT Forecast

HK$-293134919.86

2026 EBIT Forecast

HK$-285532954.27

2027 EBIT Forecast

HK$-265812144.89

2028 EBIT Forecast

HK$-266033655.01

2029 EBIT Forecast

HK$-274901443.51

2030 EBIT Forecast

HK$-278667593.29

Immunotech Biopharm Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Immunotech Biopharm Ltd's EPS has grown from HK$-0.29 to HK$-0.69 – a 137.93% increase. Next year, analysts are expecting EPS to reach HK$-0.73 – an increase of 5.42%. Over the next nine years, the forecast is for EPS to grow by 6.37%.

2022 EPS Forecast

HK$-0.73

2023 EPS Forecast

HK$-0.65

2024 EPS Forecast

HK$-0.76

2025 EPS Forecast

HK$-0.74

2026 EPS Forecast

HK$-0.74

2027 EPS Forecast

HK$-0.71